跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-LABETALOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-LABETALOL
Authorized
STANDARD
RIVA-LABETALOL
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
805af7e5ffc272c6
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
805af7e5ffc272c6
Drug Approval Canada Name
RIVA-LABETALOL
Product Name
RIVA-LABETALOL
Status
Marketed
Status Date
2019-09-04
Original Market Date
2019-09-04
Din
02489406
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AG01 LABETALOL
Atc Name
c 07 ag 01
Aig Number
0116170001
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
LABETALOL HYDROCHLORIDE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
805af7e5ffc272c6
Type
Standard
Back to Health Canada Approvals